ciprofloxacin has been researched along with Birth Weight in 3 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Birth Weight: The mass or quantity of heaviness of an individual at BIRTH. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ciprofloxacin treatment is effective in life-threatening multi-drug-resistant P." | 5.32 | Ciprofloxacin treatment in newborns with multi-drug-resistant nosocomial Pseudomonas infections. ( Belet, N; Haciömeroğlu, P; Küçüködük, S, 2004) |
| "24 preterm neonates with age < 28 days, who received intravenous ciprofloxacin 10 mg/kg/dose 12 hourly for clinical and/or culture proven sepsis, were enrolled." | 3.72 | Multiple dose pharmacokinetics of ciprofloxacin in preterm babies. ( Aggarwal, P; Dutta, S; Garg, SK; Narang, A, 2004) |
| "Ciprofloxacin treatment is effective in life-threatening multi-drug-resistant P." | 1.32 | Ciprofloxacin treatment in newborns with multi-drug-resistant nosocomial Pseudomonas infections. ( Belet, N; Haciömeroğlu, P; Küçüködük, S, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, J | 1 |
| Ding, J | 1 |
| Di, X | 1 |
| Sun, W | 1 |
| Chen, H | 1 |
| Zhang, H | 1 |
| Belet, N | 1 |
| Haciömeroğlu, P | 1 |
| Küçüködük, S | 1 |
| Aggarwal, P | 1 |
| Dutta, S | 1 |
| Garg, SK | 1 |
| Narang, A | 1 |
3 other studies available for ciprofloxacin and Birth Weight
| Article | Year |
|---|---|
Association between prenatal antibiotics exposure and measures of fetal growth: A repeated-measure study.
Topics: Anti-Bacterial Agents; Birth Weight; Ciprofloxacin; Female; Fetal Development; Humans; Infant, Newbo | 2022 |
Ciprofloxacin treatment in newborns with multi-drug-resistant nosocomial Pseudomonas infections.
Topics: Birth Weight; Ciprofloxacin; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Gestatio | 2004 |
Multiple dose pharmacokinetics of ciprofloxacin in preterm babies.
Topics: Anti-Infective Agents; Birth Weight; Ciprofloxacin; Humans; Infant, Newborn; Infant, Premature; Infa | 2004 |